Cargando…

Ischemic and Bleeding Events of Ticagrelor Monotherapy in Korean Patients With and Without Diabetes Mellitus: Insights From the TICO Trial

Background: Ticagrelor monotherapy after 3 months dual antiplatelet therapy (DAPT) with aspirin and ticagrelor can reduce bleeding without increasing ischemic events after percutaneous coronary intervention (PCI). However, the impact of this approach among the patient with diabetes remains unknown....

Descripción completa

Detalles Bibliográficos
Autores principales:	Yun, Kyeong Ho, Cho, Jae Young, Lee, Seung Yul, Rhee, Sang Jae, Kim, Byeong Keuk, Hong, Myeong Ki, Jang, Yangsoo, Oh, Seok Kyu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7845141/ https://www.ncbi.nlm.nih.gov/pubmed/33519487 http://dx.doi.org/10.3389/fphar.2020.620906

Ejemplares similares

Clinical implication of ticagrelor monotherapy in patients with small vessel coronary artery disease: results from the TICO randomized trial
por: Cho, Jae Young, et al.
Publicado: (2023)

Factors Related to Major Bleeding After Ticagrelor Therapy: Results from the TICO Trial
por: Cho, Jae Young, et al.
Publicado: (2021)

Age‐Dependent Effect of Ticagrelor Monotherapy Versus Ticagrelor With Aspirin on Major Bleeding and Cardiovascular Events: A Post Hoc Analysis of the TICO Randomized Trial
por: Kim, Byung Gyu, et al.
Publicado: (2021)

Ticagrelor Monotherapy After 3-Month Dual Antiplatelet Therapy in Acute Coronary Syndrome by High Bleeding Risk: The Subanalysis From the TICO Trial
por: Lee, Yong-Joon, et al.
Publicado: (2021)

Body mass index affecting ticagrelor monotherapy vs. ticagrelor with aspirin in patients with acute coronary syndrome: A pre-specified sub-analysis of the TICO randomized trial
por: Kim, Byung Gyu, et al.
Publicado: (2023)

The Ticos : culture and social change in Costa Rica /
por: Biesanz, Mavis Hiltunen
Publicado: (1999)

Temporal Variability of Platelet Reactivity in Patients Treated with Clopidogrel or Ticagrelor
por: Yun, Kyeong Ho, et al.
Publicado: (2019)

Randomized Comparison of Strut Coverage between Ticagrelor and Clopidogrel in Acute Myocardial Infarction at 3-Month Optical Coherence Tomography
por: Kim, Choongki, et al.
Publicado: (2018)

Commentary: Ticagrelor monotherapy—Not for CABG?
por: Sandner, Sigrid, et al.
Publicado: (2022)

Ticagrelor vs. Clopidogrel in Acute Coronary Syndrome Patients With Chronic Kidney Disease After New-Generation Drug-Eluting Stent Implantation
por: Roh, Ji Woong, et al.
Publicado: (2022)

Clinical Outcomes of Ticagrelor in Korean Patients with Acute Myocardial Infarction without High Bleeding Risk
por: Park, Keun-Ho, et al.
Publicado: (2021)

Long-term Clinical Outcomes of Drug-Eluting Stent Malapposition
por: Lee, Seung-Yul, et al.
Publicado: (2020)

The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data
por: Kim, Choongki, et al.
Publicado: (2017)

Pharmacodynamic Comparison of Ticagrelor Monotherapy Versus Ticagrelor and Aspirin in Patients After Percutaneous Coronary Intervention: The TEMPLATE (Ticagrelor Monotherapy and Platelet Reactivity) Randomized Controlled Trial
por: Johnson, Thomas W., et al.
Publicado: (2020)

Incidence, Predictors, and Clinical Outcomes of New-Onset Diabetes Mellitus after Percutaneous Coronary Intervention with Drug-Eluting Stent
por: Chun, Kyeong-Hyeon, et al.
Publicado: (2017)

Consecutive Jailed- and Kissing-Corsair Technique: Side Branch Protection and Dilation during Stent Implantation
por: Choi, Jungho, et al.
Publicado: (2019)

Safety and Efficacy of Contemporary Drug-Eluting Stents in Patients With ST-Segment Elevation Myocardial Infarction and a High Ischemic Risk
por: Lee, Oh-Hyun, et al.
Publicado: (2022)

Corrigendum: Safety and efficacy of contemporary drug-eluting stents in patients with ST-segment elevation myocardial infarction and a high ischemic risk
por: Lee, Oh-Hyun, et al.
Publicado: (2022)

Monotherapy versus combination therapy of statin and renin–angiotensin system inhibitor in ST-segment elevation myocardial infarction
por: Kim, Yong Hoon, et al.
Publicado: (2022)

Optical Coherence Tomographic Observation of Morphological Features of Neointimal Tissue after Drug-Eluting Stent Implantation
por: Lee, Seung-Yul, et al.
Publicado: (2014)

The Effect of Sex and Anthropometry on Clinical Outcomes in Patients Undergoing Percutaneous Coronary Intervention for Complex Coronary Lesions
por: Lee, Seung-Yul, et al.
Publicado: (2017)

TICO: a tool for postprocessing the predictions of prokaryotic translation initiation sites
por: Tech, M., et al.
Publicado: (2006)

Cinco ensayos cr´ticos de la economía e historia
por: Flores Nava, Fabiola Jesavel

Ticagrelor monotherapy after CABG—Probably not at all and definitely not forever
por: Sandner, Sigrid, et al.
Publicado: (2022)

Arterial Occlusive Disease Complicating Radiation Therapy of Cervical Cancer
por: Won, Ki-Bum, et al.
Publicado: (2012)

β-Fibrinogen Gene -455 G/A Polymorphism in Korean Ischemic Stroke Patients
por: Lee, Seung-Han, et al.
Publicado: (2008)

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction
por: Roh, Ji Woong, et al.
Publicado: (2021)

Comparison of Ticagrelor Monotherapy and Ticagrelor Plus Aspirin Among Patients With Acute Coronary Syndrome Combined With High-Risk of Gastrointestinal Bleeding After Percutaneous Coronary Intervention: A Retrospective Cohort Study
por: Tian, Ming-Yu, et al.
Publicado: (2023)

Migration of a sirolimus-eluting stent from the ostium of the left main coronary artery to the right deep femoral artery
por: Won, Ki-Bum, et al.
Publicado: (2013)

Comparative effect of statin intensity between prediabetes and type 2 diabetes mellitus after implanting newer-generation drug-eluting stents in Korean acute myocardial infarction patients: a retrospective observational study
por: Kim, Yong Hoon, et al.
Publicado: (2021)

Comparison of the Infarct Size between the Loading of Ticagrelor and Clopidogrel in Patients with Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention
por: Yun, Kyeong Ho, et al.
Publicado: (2017)

Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Monotherapy in Patients with Type 2 Diabetes Mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)

Successful Culotte Stenting for Unprotected Left Main Trifurcation Disease: Insights from Optical Coherence Tomography
por: Kim, Yongcheol, et al.
Publicado: (2020)

Information and communication technologies and quality of life in home confinement: Development and validation of the TICO scale
por: García del Castillo-Rodríguez, José Antonio, et al.
Publicado: (2020)

Ticagrelor monotherapy in patients with concomitant diabetes mellitus and chronic kidney disease: a post hoc analysis of the GLOBAL LEADERS trial
por: Gao, Chao, et al.
Publicado: (2020)

Long-term monotherapy with ticagrelor after coronary stenting: the GLOBAL LEADERS study
por: Greco, Antonio, et al.
Publicado: (2020)

Comparison of Optical Coherence Tomographic Assessment between First- and Second-Generation Drug-Eluting Stents
por: Kim, Byeong-Keuk, et al.
Publicado: (2012)

Ticagrelor Resistance in Cardiovascular Disease and Ischemic Stroke
por: He, Song, et al.
Publicado: (2023)

Severe Acute Stent Malapposition After Drug‐Eluting Stent Implantation: Effects on Long‐Term Clinical Outcomes
por: Lee, Seung‐Yul, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_au73dc25ae7dchn413po823tre